CellbXhealth (CLBX)

Sector:

Support

Index:

FTSE AIM All-Share

 1.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 7.50
  • 52 Week Low: 0.82
  • Currency: UK Pounds
  • Shares Issued: 1,139.40m
  • Volume: 737,020
  • Market Cap: £14.24m
  • Beta: 0.02

Latest ShareCast News

CelLBxHealth enters service agreement with AstraZeneca, shares pop

By Josh White

Date: Friday 29 May 2026

(Sharecast News) - CelLBxHealth said on Friday that it had entered into a master services agreement with AstraZeneca, establishing the company as a qualified service provider to the global pharmaceutical group.

CelLBxHealth warns of lower-than-expected 2025 revenue

By Josh White

Date: Friday 16 Jan 2026

(Sharecast News) - CelLBxHealth said in an update on Friday that it expected to report lower-than-anticipated revenues for 2025 after the deferral of several sales contracts, while highlighting a strong cash position and significant cost reductions as it positions the business for commercial progress in 2026.

Holding(s) in Company

By Sharecast

Date: Tuesday 23 Dec 2025

PDMR Dealing and ESOT Share Purchase 19-Dec-2025 ShareCast
Angle founder and CEO steps down after sharehold... 12-Sep-2025 ShareCast
Shares in Angle tumble on gloomy outlook 09-Sep-2025 ShareCast
Angle reviewing board structure as two directors... 06-Jun-2025 ShareCast
Angle slumps on cautious outlook 28-May-2025 ShareCast
Angle completes assay development projects 21-Mar-2025 ShareCast
Angle's Parsortix system used in 'breakthrough' ... 24-Jan-2025 ShareCast
Berenberg slashes target price on Angle 23-Jan-2025 ShareCast
Angle signs new agreement US biotech Recursion 19-Sep-2024 ShareCast
Angle unveils plans to raise more than £10m 05-Jun-2024 ShareCast
Angle reports promising results from Parsortix s... 16-May-2024 ShareCast
Angle strikes supplier deal with AstraZeneca 03-May-2024 ShareCast
Angle granted European patent for CellKeep, US p... 22-Apr-2024 ShareCast
Angle receives 'breakthrough results' from DNA m... 04-Jan-2024 ShareCast
Angle locks in $250,000 contract with Eisai 02-Jan-2024 ShareCast
Angle losses widen in 'breakthrough year' 21-Apr-2023 ShareCast
Tougher market conditions impacting Angle clients 05-Jan-2023 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CellbXhealth Market Data

Currency UK Pounds
Share Price 1.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 7.50
52 Week Low 0.82
Volume 737,020
Shares Issued 1,139.40m
Market Cap £14.24m
Beta 0.02

CellbXhealth Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
19.42% below the market average19.42% below the market average19.42% below the market average19.42% below the market average19.42% below the market average
36.47% above the sector average36.47% above the sector average36.47% above the sector average36.47% above the sector average36.47% above the sector average
Price Trend
85.01% below the market average85.01% below the market average85.01% below the market average85.01% below the market average85.01% below the market average
87.1% below the sector average87.1% below the sector average87.1% below the sector average87.1% below the sector average87.1% below the sector average
Income Not Available
Growth
54.99% above the market average54.99% above the market average54.99% above the market average54.99% above the market average54.99% above the market average
56.82% above the sector average56.82% above the sector average56.82% above the sector average56.82% above the sector average56.82% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CellbXhealth Dividends

No dividends found

Trades for 25-Aug-2026

Time Volume / Share Price
16:26 100,000 @ 1.21p
14:00 200,000 @ 1.27p
11:02 20,126 @ 1.27p
09:58 200,000 @ 1.27p
09:48 4,557 @ 1.20p

CellbXhealth Key Personnel

CEO Peter Collins

Top of Page